| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein phosphatase binding | 8.88e-04 | 210 | 41 | 4 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | 2.06e-03 | 264 | 41 | 4 | GO:0019902 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 1.88e-05 | 166 | 41 | 5 | GO:0098773 | |
| GeneOntologyBiologicalProcess | insulin receptor recycling | 3.84e-05 | 5 | 41 | 2 | GO:0038020 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 4.39e-05 | 198 | 41 | 5 | GO:0048754 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 7.37e-05 | 41 | 41 | 3 | GO:0061436 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 1.01e-04 | 236 | 41 | 5 | GO:0061138 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 1.53e-04 | 258 | 41 | 5 | GO:0001763 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 1.71e-04 | 421 | 41 | 6 | GO:0060562 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.96e-04 | 619 | 41 | 7 | GO:0002009 | |
| GeneOntologyCellularComponent | keratohyalin granule | 6.98e-08 | 5 | 41 | 3 | GO:0036457 | |
| GeneOntologyCellularComponent | cornified envelope | 1.00e-05 | 69 | 41 | 4 | GO:0001533 | |
| HumanPheno | Aplasia/Hypoplasia of the sternum | 2.39e-05 | 19 | 16 | 3 | HP:0006714 | |
| HumanPheno | Short 1st metacarpal | 7.10e-05 | 27 | 16 | 3 | HP:0010034 | |
| HumanPheno | Short proximal phalanx of finger | 1.19e-04 | 32 | 16 | 3 | HP:0010241 | |
| HumanPheno | Aplasia/Hypoplasia of the 1st metacarpal | 1.43e-04 | 34 | 16 | 3 | HP:0010026 | |
| HumanPheno | Short phalanx of the thumb | 1.85e-04 | 37 | 16 | 3 | HP:0009660 | |
| HumanPheno | Aplasia/Hypoplasia of the proximal phalanges of the hand | 2.17e-04 | 39 | 16 | 3 | HP:0009851 | |
| HumanPheno | Abnormal 1st metacarpal morphology | 2.34e-04 | 40 | 16 | 3 | HP:0010009 | |
| Domain | Filaggrin | 4.70e-06 | 2 | 41 | 2 | IPR003303 | |
| Domain | S100_CABP | 2.77e-05 | 27 | 41 | 3 | PS00303 | |
| Domain | S_100 | 2.77e-05 | 27 | 41 | 3 | PF01023 | |
| Domain | S100_Ca-bd_sub | 3.10e-05 | 28 | 41 | 3 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 3.10e-05 | 28 | 41 | 3 | IPR001751 | |
| Domain | S_100 | 3.10e-05 | 28 | 41 | 3 | SM01394 | |
| Domain | Galactose-bd-like | 5.28e-05 | 94 | 41 | 4 | IPR008979 | |
| Domain | RRM_1 | 1.10e-03 | 208 | 41 | 4 | PF00076 | |
| Domain | RRM | 1.28e-03 | 217 | 41 | 4 | SM00360 | |
| Domain | RRM_dom | 1.51e-03 | 227 | 41 | 4 | IPR000504 | |
| Domain | RRM | 1.59e-03 | 230 | 41 | 4 | PS50102 | |
| Domain | IGc2 | 1.72e-03 | 235 | 41 | 4 | SM00408 | |
| Domain | Ig_sub2 | 1.72e-03 | 235 | 41 | 4 | IPR003598 | |
| Domain | IG | 2.18e-03 | 421 | 41 | 5 | SM00409 | |
| Domain | Ig_sub | 2.18e-03 | 421 | 41 | 5 | IPR003599 | |
| Domain | Nucleotide-bd_a/b_plait | 2.41e-03 | 258 | 41 | 4 | IPR012677 | |
| Domain | IG_LIKE | 4.23e-03 | 491 | 41 | 5 | PS50835 | |
| Domain | Ig-like_dom | 4.68e-03 | 503 | 41 | 5 | IPR007110 | |
| Domain | fn3 | 5.36e-03 | 162 | 41 | 3 | PF00041 | |
| Domain | EF_Hand_1_Ca_BS | 6.64e-03 | 175 | 41 | 3 | IPR018247 | |
| Domain | FN3 | 7.73e-03 | 185 | 41 | 3 | SM00060 | |
| Domain | Ig_I-set | 8.32e-03 | 190 | 41 | 3 | IPR013098 | |
| Domain | ig | 8.32e-03 | 190 | 41 | 3 | PF00047 | |
| Domain | Immunoglobulin | 8.32e-03 | 190 | 41 | 3 | IPR013151 | |
| Domain | I-set | 8.32e-03 | 190 | 41 | 3 | PF07679 | |
| Domain | FN3 | 9.43e-03 | 199 | 41 | 3 | PS50853 | |
| Domain | EF_HAND_1 | 1.01e-02 | 204 | 41 | 3 | PS00018 | |
| Domain | FN3_dom | 1.08e-02 | 209 | 41 | 3 | IPR003961 | |
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 1.52e-09 | 3 | 41 | 3 | 23403047 | |
| Pubmed | Activation of beta-catenin signaling programs embryonic epidermis to hair follicle fate. | 6.63e-08 | 33 | 41 | 4 | 18480165 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 7.63e-08 | 91 | 41 | 5 | 34445801 | |
| Pubmed | 5.09e-07 | 613 | 41 | 8 | 22268729 | ||
| Pubmed | 8.42e-07 | 16 | 41 | 3 | 31823782 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.31e-06 | 477 | 41 | 7 | 31300519 | |
| Pubmed | Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep. | 1.36e-06 | 2 | 41 | 2 | 27678121 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24813994 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 1.99e-06 | 21 | 41 | 3 | 19601998 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 3.69e-06 | 558 | 41 | 7 | 27591049 | |
| Pubmed | The transcription factors Sox5 and Sox9 regulate Catsper1 gene expression. | 4.06e-06 | 3 | 41 | 2 | 25101494 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 29042436 | ||
| Pubmed | GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. | 4.06e-06 | 3 | 41 | 2 | 28928464 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 32437351 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 6.27e-06 | 605 | 41 | 7 | 28977666 | |
| Pubmed | 6.43e-06 | 223 | 41 | 5 | 33731348 | ||
| Pubmed | 7.85e-06 | 107 | 41 | 4 | 32989256 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 27703010 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 8.82e-06 | 238 | 41 | 5 | 35864588 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 9.41e-06 | 420 | 41 | 6 | 28065597 | |
| Pubmed | 1.01e-05 | 245 | 41 | 5 | 35652658 | ||
| Pubmed | 1.06e-05 | 36 | 41 | 3 | 31669268 | ||
| Pubmed | 1.35e-05 | 260 | 41 | 5 | 36199071 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 27304082 | ||
| Pubmed | 2.14e-05 | 286 | 41 | 5 | 32041737 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.28e-05 | 1082 | 41 | 8 | 38697112 | |
| Pubmed | 3.62e-05 | 54 | 41 | 3 | 35474131 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 10760573 | ||
| Pubmed | Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization. | 3.78e-05 | 8 | 41 | 2 | 26659946 | |
| Pubmed | Robo4 is a vascular-specific receptor that inhibits endothelial migration. | 3.78e-05 | 8 | 41 | 2 | 12941633 | |
| Pubmed | 4.04e-05 | 56 | 41 | 3 | 37059927 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 23746980 | ||
| Pubmed | 5.29e-05 | 346 | 41 | 5 | 25324306 | ||
| Pubmed | 5.36e-05 | 347 | 41 | 5 | 16033648 | ||
| Pubmed | 5.48e-05 | 62 | 41 | 3 | 19463158 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 5.48e-05 | 62 | 41 | 3 | 28344315 | |
| Pubmed | 6.03e-05 | 64 | 41 | 3 | 36636478 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 19261698 | ||
| Pubmed | Wnt4 is required for proper male as well as female sexual development. | 6.07e-05 | 10 | 41 | 2 | 15581876 | |
| Pubmed | SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein. | 6.61e-05 | 66 | 41 | 3 | 36095012 | |
| Pubmed | 7.02e-05 | 187 | 41 | 4 | 29777862 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 24355925 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 33515576 | ||
| Pubmed | VEGF receptor 2 (KDR) protects airways from mucus metaplasia through a Sox9-dependent pathway. | 7.41e-05 | 11 | 41 | 2 | 34010630 | |
| Pubmed | Prdm6 controls heart development by regulating neural crest cell differentiation and migration. | 7.41e-05 | 11 | 41 | 2 | 35108221 | |
| Pubmed | Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development. | 7.41e-05 | 11 | 41 | 2 | 17470636 | |
| Pubmed | 8.58e-05 | 197 | 41 | 4 | 23686814 | ||
| Pubmed | 8.88e-05 | 12 | 41 | 2 | 11381080 | ||
| Pubmed | 8.88e-05 | 12 | 41 | 2 | 17460146 | ||
| Pubmed | LncRNA SAMD12-AS1 promotes cell proliferation and inhibits apoptosis by interacting with NPM1. | 8.88e-05 | 12 | 41 | 2 | 31406141 | |
| Pubmed | Wnt ligands signal in a cooperative manner to promote foregut organogenesis. | 8.88e-05 | 12 | 41 | 2 | 22949635 | |
| Pubmed | 1.03e-04 | 399 | 41 | 5 | 35987950 | ||
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 17014841 | ||
| Pubmed | Blimp1 regulates the transition of neonatal to adult intestinal epithelium. | 1.05e-04 | 13 | 41 | 2 | 21878906 | |
| Pubmed | PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78. | 1.22e-04 | 14 | 41 | 2 | 29178343 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 1.27e-04 | 218 | 41 | 4 | 35831895 | |
| Pubmed | 1.29e-04 | 418 | 41 | 5 | 35338135 | ||
| Pubmed | 1.31e-04 | 83 | 41 | 3 | 19799774 | ||
| Pubmed | CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase. | 1.41e-04 | 15 | 41 | 2 | 26503042 | |
| Pubmed | The septum transversum mesenchyme induces gall bladder development. | 1.41e-04 | 15 | 41 | 2 | 23951403 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.47e-04 | 430 | 41 | 5 | 35044719 | |
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 30579834 | ||
| Pubmed | 1.66e-04 | 234 | 41 | 4 | 36243803 | ||
| Pubmed | Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease. | 1.82e-04 | 17 | 41 | 2 | 29371594 | |
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 22306086 | ||
| Pubmed | 1.95e-04 | 244 | 41 | 4 | 29884807 | ||
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 23884891 | ||
| Pubmed | 2.27e-04 | 100 | 41 | 3 | 21800051 | ||
| Pubmed | 2.29e-04 | 19 | 41 | 2 | 32579270 | ||
| Pubmed | 2.29e-04 | 19 | 41 | 2 | 21508241 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 2.34e-04 | 256 | 41 | 4 | 32698014 | |
| Pubmed | 2.40e-04 | 754 | 41 | 6 | 35906200 | ||
| Pubmed | KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. | 2.54e-04 | 20 | 41 | 2 | 28199306 | |
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 22911573 | ||
| Pubmed | Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. | 2.54e-04 | 20 | 41 | 2 | 26033091 | |
| Pubmed | Wntless is required for peripheral lung differentiation and pulmonary vascular development. | 2.54e-04 | 20 | 41 | 2 | 23523683 | |
| Pubmed | Partners of wild type Grb7 and a mutant lacking its calmodulin-binding domain. | 2.81e-04 | 21 | 41 | 2 | 32360748 | |
| Pubmed | Cooperation of BMP and IHH signaling in interdigital cell fate determination. | 2.81e-04 | 21 | 41 | 2 | 29771958 | |
| Pubmed | Lack of Flvcr2 impairs brain angiogenesis without affecting the blood-brain barrier. | 3.09e-04 | 22 | 41 | 2 | 32369453 | |
| Pubmed | 3.09e-04 | 22 | 41 | 2 | 17544391 | ||
| Pubmed | Deletion of hypoxia-responsive microRNA-210 results in a sex-specific decrease in nephron number. | 3.09e-04 | 22 | 41 | 2 | 32141129 | |
| Pubmed | 3.34e-04 | 281 | 41 | 4 | 26725010 | ||
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 25523391 | ||
| Pubmed | The Sox9 transcription factor determines glial fate choice in the developing spinal cord. | 3.38e-04 | 23 | 41 | 2 | 12842915 | |
| Pubmed | 3.43e-04 | 115 | 41 | 3 | 17332742 | ||
| Pubmed | TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1. | 3.60e-04 | 117 | 41 | 3 | 36898370 | |
| Pubmed | E-cadherin is required for intestinal morphogenesis in the mouse. | 3.68e-04 | 24 | 41 | 2 | 22766025 | |
| Pubmed | 4.00e-04 | 25 | 41 | 2 | 36046192 | ||
| Pubmed | 4.00e-04 | 25 | 41 | 2 | 16887829 | ||
| Pubmed | BMP4 and Wnt signaling interact to promote mouse tracheal mesenchyme morphogenesis. | 4.33e-04 | 26 | 41 | 2 | 34851738 | |
| Pubmed | 4.49e-04 | 304 | 41 | 4 | 32235678 | ||
| Pubmed | 4.59e-04 | 551 | 41 | 5 | 34728620 | ||
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 4.67e-04 | 27 | 41 | 2 | 18649358 | |
| Pubmed | 4.67e-04 | 27 | 41 | 2 | 26544073 | ||
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 5.03e-04 | 28 | 41 | 2 | 27002738 | |
| Pubmed | 5.03e-04 | 28 | 41 | 2 | 17126317 | ||
| Pubmed | 5.03e-04 | 28 | 41 | 2 | 18593464 | ||
| Pubmed | 5.39e-04 | 29 | 41 | 2 | 25336744 | ||
| Pubmed | 5.39e-04 | 29 | 41 | 2 | 34267243 | ||
| Pubmed | HAND2 Target Gene Regulatory Networks Control Atrioventricular Canal and Cardiac Valve Development. | 5.78e-04 | 30 | 41 | 2 | 28538179 | |
| Interaction | CUL2 interactions | 2.29e-06 | 591 | 41 | 9 | int:CUL2 | |
| Interaction | KHDRBS2 interactions | 6.19e-06 | 129 | 41 | 5 | int:KHDRBS2 | |
| Cytoband | 1q21.3 | 1.60e-04 | 117 | 41 | 3 | 1q21.3 | |
| Cytoband | Xq23 | 1.00e-03 | 52 | 41 | 2 | Xq23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq23 | 2.90e-03 | 89 | 41 | 2 | chrXq23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 5.63e-03 | 404 | 41 | 3 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 6.35e-03 | 422 | 41 | 3 | chr20q13 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 1.04e-07 | 7 | 27 | 3 | 1350 | |
| GeneFamily | RNA binding motif containing | 2.66e-04 | 213 | 27 | 4 | 725 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.62e-03 | 40 | 27 | 2 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 1.70e-03 | 160 | 27 | 3 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.73e-03 | 161 | 27 | 3 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 2.90e-03 | 193 | 27 | 3 | 594 | |
| GeneFamily | EF-hand domain containing | 4.14e-03 | 219 | 27 | 3 | 863 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.04e-02 | 394 | 27 | 3 | 471 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN | 4.45e-07 | 187 | 41 | 6 | M6691 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-07 | 180 | 41 | 5 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-07 | 180 | 41 | 5 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.12e-07 | 193 | 41 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.12e-07 | 193 | 41 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.35e-07 | 194 | 41 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.35e-07 | 194 | 41 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 100 | 41 | 4 | 97ca9cda55a05fbb4d1f5d61f847c965e014f05c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 161 | 41 | 4 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-05 | 170 | 41 | 4 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-05 | 170 | 41 | 4 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 2.05e-05 | 176 | 41 | 4 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 2.28e-05 | 181 | 41 | 4 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-05 | 185 | 41 | 4 | 0ab1be455f2cd883c9d1522ca78112c37833352e | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 188 | 41 | 4 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 2.71e-05 | 189 | 41 | 4 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | da2fcd4a2cc6e45c8174109d892f1424e39919a1 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.76e-05 | 190 | 41 | 4 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 190 | 41 | 4 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | facs-GAT-Fat-24m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 9aaa48f3aad813c87a45efdbb67d255c94f6e6a4 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 34e56c5e7ea6a8f227dbaefe73cbb8818d18b523 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 14cdb660ad3aabcf49572173e7628d8b99dcbe6f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 190 | 41 | 4 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | a0018f88f7132477cc467ee15db029a585290595 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | 6b9bbf4a63d4e9a8075bb06c2aa644fcf4ee88b8 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | 90f0c193dce267a4f1a9b2501f636dafd0a34cf7 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 192 | 41 | 4 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 2.88e-05 | 192 | 41 | 4 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 192 | 41 | 4 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 192 | 41 | 4 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | ba9a47e2dc01efa6d2a99b1631d4951fac2648d4 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-05 | 193 | 41 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | e164f6403a8b541ced08a6feec915d2e855036ea | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | 724bb613fa434add5b1c5586b629328f819fbdfe | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-05 | 193 | 41 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-05 | 193 | 41 | 4 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | facs-MAT-Fat-3m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | b32533afeff1905e188becaa09079e9699722e4b | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-05 | 193 | 41 | 4 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | facs-MAT-Fat-24m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | 737e540c72a3cfe8dbd4c0f139f7d729a166793a | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.94e-05 | 193 | 41 | 4 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | 2ff573ba2c74583ed1cb071a3bbc01bb71117e5f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 194 | 41 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 194 | 41 | 4 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 194 | 41 | 4 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | b8a130ffae68ffe550bf335460a1ec1035cf8d8d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 195 | 41 | 4 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 196 | 41 | 4 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 196 | 41 | 4 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 196 | 41 | 4 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.12e-05 | 196 | 41 | 4 | 1d94cecd378a829dd8014fc086d7fca48c953a91 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.12e-05 | 196 | 41 | 4 | aacec48285bcb7ccf1b538187071885e3602cc49 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 197 | 41 | 4 | 7caa2c86dc4d50b57a7db8f7278d1588282ad6db | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 197 | 41 | 4 | 951f18f326967206adbbfc422cce9eea3d2e0854 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 115 | 41 | 3 | e11128262ba1e2a7053b1b6c039f1aab37d2ce27 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 128 | 41 | 3 | e100629f6038e32176ffcc81bd06bd175df46cef | |
| ToppCell | ASK440-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.01e-04 | 142 | 41 | 3 | ea694a907eaa46c55665692cb830870281700e40 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 154 | 41 | 3 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 154 | 41 | 3 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 154 | 41 | 3 | 4c2a7590791c2255b15dab82c3622f71f9ffd949 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.11e-04 | 158 | 41 | 3 | 1635a85fc73c544028418087f36d28957dd4f458 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.11e-04 | 158 | 41 | 3 | 80841dadfa53bcde36a3e486408a095f78e772eb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-04 | 158 | 41 | 3 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 159 | 41 | 3 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 159 | 41 | 3 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 159 | 41 | 3 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.26e-04 | 160 | 41 | 3 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 162 | 41 | 3 | 3a1cbfed5a063131d49e3c1584f62b12660ecb36 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 162 | 41 | 3 | 04b3c38bb27fa369a9ac5b60883f8b058abc5180 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 162 | 41 | 3 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 162 | 41 | 3 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 162 | 41 | 3 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-04 | 164 | 41 | 3 | d7053de88ef8e42cac6726a40e72f212659ee034 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 4.66e-04 | 165 | 41 | 3 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.74e-04 | 166 | 41 | 3 | 006ced12f69ef13ddcba5a3891ddc7c18c384863 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.74e-04 | 166 | 41 | 3 | 68e6fc7c0040bbe48a93f96ecf28afffdc626845 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.74e-04 | 166 | 41 | 3 | ac28c8cac1e94be0c47fb862c5809c92cdaa11f3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-04 | 166 | 41 | 3 | a42268a02a89fc97272e45c4cbe21acf04b7428c | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-04 | 166 | 41 | 3 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-04 | 166 | 41 | 3 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 5.00e-04 | 169 | 41 | 3 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-04 | 169 | 41 | 3 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.08e-04 | 170 | 41 | 3 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM5|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.08e-04 | 170 | 41 | 3 | b2daf46ab5a49590ede8f75e4240bfe6e9d8b764 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-04 | 170 | 41 | 3 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-04 | 170 | 41 | 3 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-04 | 170 | 41 | 3 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| Disease | cystic kidney disease (implicated_via_orthology) | 7.22e-05 | 10 | 38 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of lung | 3.74e-04 | 266 | 38 | 4 | C0242379 | |
| Disease | Adenocarcinoma | 4.52e-04 | 116 | 38 | 3 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 4.52e-04 | 116 | 38 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 4.52e-04 | 116 | 38 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 4.52e-04 | 116 | 38 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 4.52e-04 | 116 | 38 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 4.52e-04 | 116 | 38 | 3 | C0205641 | |
| Disease | colorectal cancer (is_implicated_in) | 5.11e-04 | 121 | 38 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | Ischemic stroke | 7.85e-04 | 324 | 38 | 4 | HP_0002140 | |
| Disease | high grade glioma (is_marker_for) | 1.35e-03 | 42 | 38 | 2 | DOID:3070 (is_marker_for) | |
| Disease | colitis (biomarker_via_orthology) | 1.35e-03 | 42 | 38 | 2 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1.90e-03 | 50 | 38 | 2 | C1862939 | |
| Disease | Respiratory Distress Syndrome, Adult | 2.30e-03 | 55 | 38 | 2 | C0035222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYSDSGYQEAGSFHN | 151 | Q99569 | |
| SSVGSYQRGISDYHS | 251 | Q8NEC5 | |
| NDSTYDGHTVGGLQY | 211 | Q08345 | |
| GNHGNSYSIASGEYL | 1201 | Q9HAR2 | |
| YSGSQASDNEGHSED | 3011 | P20930 | |
| SADYDYGESGFRHSQ | 3981 | P20930 | |
| DSAGYTALHYASRNG | 61 | Q53RE8 | |
| NSQGTESSLYAHGYL | 446 | P98175 | |
| SYGAQAASYGAQSAA | 376 | Q96PK6 | |
| SVYAVSSNHSAAYNG | 216 | Q9NP74 | |
| SSNHSAAYNGTDGLA | 221 | Q9NP74 | |
| SGHSEYSDSEGYSGV | 1726 | Q5D862 | |
| STYGESYDHSSNAGF | 441 | Q8IZ02 | |
| GDNSLHSYADFSGAT | 596 | Q96IV0 | |
| AQAGSYEGFDQSQSH | 546 | Q7Z3F1 | |
| LTEGHSGNYYCTADN | 531 | Q96RD9 | |
| YAASNTGDHADEQDG | 46 | Q12980 | |
| HYGGTATFYLSQAAD | 371 | P51570 | |
| SYSGQSSSYGEQNSD | 171 | Q86YZ3 | |
| YSYSRGHYESGSGQT | 331 | Q86YZ3 | |
| TGRNSSINSHGVDYY | 986 | P09848 | |
| NVYSGFGFHSAQDSA | 3146 | O15230 | |
| EHYSNCGYSVALGTN | 36 | O14522 | |
| YQANYGFSNDGASSS | 71 | O43719 | |
| STDKDTAYGSFQNGH | 1216 | Q5JSL3 | |
| TSKSCEYNGTTYQHG | 111 | Q9BU40 | |
| HYGSGSLSGYLSQDT | 141 | P07339 | |
| SATAGYSQFYSNGGH | 681 | Q12906 | |
| AGQYNSHLYGTSVQS | 601 | P78352 | |
| SIGSSYNYGNEDQAE | 186 | Q9NXV2 | |
| GSSNAFTSGEHTNYY | 136 | P14735 | |
| AATSYDGSALAAYGD | 156 | Q6UWW8 | |
| SSYSDHAANDSDFGS | 386 | Q1XH10 | |
| QNSSSYYSHAAGQGT | 446 | P48436 | |
| YDEEADNHGGSQYAS | 1261 | Q13023 | |
| SHYSSAQGGSQHYQG | 196 | O75177 | |
| HGYSTGYDDLTQGTA | 961 | Q5T6F2 | |
| STYSDDNFGNYSDDN | 141 | P61129 | |
| SSSNSYGQSHHYGGE | 406 | Q8N7X1 | |
| SSSNSYGQSHRYGGE | 536 | Q8N7X1 | |
| AYSGGHDSSSQSNRY | 571 | Q8N7X1 | |
| NAYSGGRDSSSNSYD | 836 | Q8N7X1 | |
| SYDQNTGGSYNSSDR | 1141 | Q9Y6N7 | |
| PDYSDAENGHDYGSS | 241 | Q6UXY8 | |
| SEGSNQTSGYQSGYH | 1296 | P35968 | |
| QTSGYQSGYHSDDTD | 1301 | P35968 | |
| SASDSTYAHGNGYQE | 91 | Q8ND25 | |
| AASAYDYGSSHGLTD | 86 | P52179 |